Viral hepatitis | German Center for Infection Research

Skip to main content

Short description

Viral hepatitis is an infection caused by hepatitis viruses that damages the liver.

Detailed description

Acute viral hepatitis is common in Germany. It is caused by hepatitis viruses A through E. Infections with hepatitis viruses B, C, and D can lead to a chronic course of disease and cirrhosis of the liver. Symptoms initially include flu-like symptoms. Later, they also often include yellowing of the skin.

Prof. Ralf Bartenschlager

Bartenschlager receives the Hector Science Award

Heidelberg virologist Prof Ralf Bartenschlager has received Science Award of the Hector-Stiftung, worth 150,000 euros.

With this, the Hector Stiftung’s jury honours Bartenschlager’s outstanding

Prof. Florian Klein, University Hospital Cologne

Florian Klein receives DZIF Prize for translational infection research

Florian Klein’s main goal is to improve HIV therapy with the help of antibodies and to develop a HIV vaccine. His research on a new generation of broadly neutralising antibodies has found worldwide

Aug 2018

J Hepatol

Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany

Autoren

Herzer K et al.

Prof. Dr. M. Cornberg and F. Rinker

New approach to chronic hepatitis B treatment

In chronic hepatitis B patients, a discontinuation of treatment can lead to cure: as scientists from the Hannover Medical School (MHH) have discovered. DZIF researcher Prof Markus Cornberg and his

No entry for Hepatitis D viruses (red; left) in hepatocytes with Myrcludex B (right).

Myrcludex B: First-in-class drug for the treatment of hepatitis B and D

DZIF scientists at the Heidelberg University Hospital developed a virus blocker against hepatitis B and D, which has been successful in two clinical trials

Around 350 million people suffer from

World Hepatitis Day

NOhep … for a world without hepatitis

Today’s World Hepatitis Day sets an ambitious goal: to eliminate viral hepatitis, especially hepatitis B and C, from the planet by 2030. Germany has also joined this international campaign. Scientists

Hepatitis B viruses (big oval structures with dark core)

Tricks of Ticking time bomb Hepatitis B Virus

Providing a new paradigm to hepatitis B understanding, researchers at the German Cancer Research Center (DKFZ), the Heidelberg University Hospital and the German Center for Infection Research (DZIF)

N/A

New treatment approach found for hepatitis B

DZIF scientists from the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology have identified two sequences in the hepatitis B virus (HBV) genome that could be targeted for

Multi-layered images of lungs help diagnosis and therapy.

New training programme for clinical infectious disease specialists

Today, a new training programme for clinical infectious disease specialists has started, which is probably the first of its kind in Germany. In Hamburg-Lübeck-Borstel, the northernmost partner site of

Preisträger 2014

The first ever DZIF prize goes to a hepatitis researcher

(26/11/2014) Virologist Stephan Urban from the University of Heidelberg will receive the DZIF Prize for Translational Infection Research, worth 5000 Euros. It will be awarded for the first time at the